Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
Review Meta Analysis
What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression.
Experience with intravenous and aerosolized forms of colistin for the treatment of ventilator-associated pneumonia (VAP) in patients without cystic fibrosis is limited. We aimed to assess the safety and efficacy of colistin for the treatment of VAP. ⋯ Our results suggest that colistin may be as safe and as efficacious as standard antibiotics for the treatment of VAP.